株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

チロシンキナーゼ阻害剤の世界市場:分析と傾向 - 産業動向の予測

Global Tyrosine Kinase Inhibitors Market Analysis & Trends - Industry Forecast to 2027

発行 Accuray Research 商品コード 780561
出版日 ページ情報 英文 192 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
チロシンキナーゼ阻害剤の世界市場:分析と傾向 - 産業動向の予測 Global Tyrosine Kinase Inhibitors Market Analysis & Trends - Industry Forecast to 2027
出版日: 2019年01月01日 ページ情報: 英文 192 Pages
概要

当レポートでは、世界のチロシンキナーゼ阻害剤の市場について分析し、全体的な市場規模の推移や見通し (過去3年間・今後10年間分)、製品別・用途別・流通チャネル別・地域別の詳細動向、主な市場促進・抑制要因、市場の求心力、今後の市場機会などを調査しております。

第1章 分析概要

第2章 エグゼクティブ・サマリー

第3章 市場概要

  • 市場動向
    • がん診断の知名度の上昇
    • 開発領域・TKIの拡張
    • 高品質製品の技術進歩
    • 成長機会/投資機会
  • 市場促進要因
  • 市場抑制要因
  • 業界の求心力:ポーターのファイブフォース分析

第4章 チロシンキナーゼ阻害剤市場:製品別

  • 上皮成長因子受容体(EGFR)チロシンキナーゼ阻害剤
  • 血管内皮細胞増殖因子(VEGFR)チロシンキナーゼ阻害剤
  • BCR-ABLチロシンキナーゼ阻害剤
  • その他

第5章 チロシンキナーゼ阻害剤市場:用途別

  • 腎細胞がん
  • 肺がん
  • 慢性骨髄性白血病 (CML)
  • 乳がん
  • その他の用途

第6章 チロシンキナーゼ阻害剤市場:流通チャネル

  • 独立系薬局
  • オンライン薬局
  • 院内薬局

第7章 チロシンキナーゼ阻害剤市場:地域別

  • 北米 (米国、カナダ、メキシコ)
  • 欧州 (フランス、ドイツ、イタリア、スペイン、英国など)
  • アジア太平洋地域 (中国、日本、インド、オーストラリア、ニュージーランドなど)
  • 中東 (サウジアラビア、UAEなど)
  • ラテンアメリカ (アルゼンチン、ブラジルなど)
  • 他の国々 (RoW:南アフリカなど)

第8章 主要企業の近年の活動

  • 企業合併・買収 (M&A)
  • 事業提携・協力、合弁事業、合意
  • 製品発売、事業拡張
  • その他の活動

第9章 代表的企業

  • Tolero Pharmaceutical
  • Sanofi
  • QIAGEN
  • Pfizer
  • Onyx pharmaceuticals
  • Novartis
  • Merck
  • Johnson & Johnson
  • Incyte Corporation
  • GalaxoSmithKline
  • Exelixis
  • 中外製薬
  • Celgene Corporation
  • Bristol-Myer Squibb
  • Boehringer Ingelheim
  • Biogen Idec
  • Bayer Healthcare Pharmaceuticals
  • AstraZeneca
  • Array Pharmaceuticals
  • Advenchen Laboratories
図表

List of Tables

  • Table 1 Global Tyrosine Kinase Inhibitors Market By Region, Market Forecast (2015-2027) (US$ MN)
  • Table 2 Global Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 3 Global Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 4 Global Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 5 Global Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 6 Global Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 7 Global Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 8 Global Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 9 Global Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 10 Global Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 11 Global Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 12 Global Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 13 Global Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 14 Global Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 15 Global Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 16 Global Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 17 North America Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 18 North America Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 19 North America Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 20 North America Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 21 North America Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 22 North America Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 23 North America Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 24 North America Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 25 North America Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 26 North America Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 27 North America Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 28 North America Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 29 North America Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 30 North America Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 31 North America Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 32 North America Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 33 Europe Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 34 Europe Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 35 Europe Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 36 Europe Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 37 Europe Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 38 Europe Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 39 Europe Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 40 Europe Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 41 Europe Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 42 Europe Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 43 Europe Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 44 Europe Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 45 Europe Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 46 Europe Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 47 Europe Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 48 Europe Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 49 Asia Pacific Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 50 Asia Pacific Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 51 Asia Pacific Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 52 Asia Pacific Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 53 Asia Pacific Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 54 Asia Pacific Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 55 Asia Pacific Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 56 Asia Pacific Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 57 Asia Pacific Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 58 Asia Pacific Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 59 Asia Pacific Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 60 Asia Pacific Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 61 Asia Pacific Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 62 Asia Pacific Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 63 Asia Pacific Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 64 Asia Pacific Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 65 Middle East Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 66 Middle East Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 67 Middle East Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 68 Middle East Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 69 Middle East Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 70 Middle East Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 71 Middle East Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 72 Middle East Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 73 Middle East Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 74 Middle East Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 75 Middle East Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 76 Middle East Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 77 Middle East Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 78 Middle East Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 79 Middle East Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 80 Middle East Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 81 Latin America Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 82 Latin America Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 83 Latin America Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 84 Latin America Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 85 Latin America Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 86 Latin America Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 87 Latin America Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 88 Latin America Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 89 Latin America Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 90 Latin America Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 91 Latin America Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 92 Latin America Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 93 Latin America Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 94 Latin America Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 95 Latin America Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 96 Latin America Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 97 RoW Tyrosine Kinase Inhibitors Market By Country, Market Forecast (2015-2027) (US$ MN)
  • Table 98 RoW Tyrosine Kinase Inhibitors Market By Product, Market Forecast (2015-2027) (US$ MN)
  • Table 99 RoW Tyrosine Kinase Inhibitors Market By Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 100 RoW Tyrosine Kinase Inhibitors Market By Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 101 RoW Tyrosine Kinase Inhibitors Market By BCR-ABL Tyrosine Kinase Inhibitors, Market Forecast (2015-2027) (US$ MN)
  • Table 102 RoW Tyrosine Kinase Inhibitors Market By Other Products, Market Forecast (2015-2027) (US$ MN)
  • Table 103 RoW Tyrosine Kinase Inhibitors Market By Application, Market Forecast (2015-2027) (US$ MN)
  • Table 104 RoW Tyrosine Kinase Inhibitors Market By Renal Cell Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 105 RoW Tyrosine Kinase Inhibitors Market By Lung Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 106 RoW Tyrosine Kinase Inhibitors Market By Chronic Myeloid Leukemia (CML), Market Forecast (2015-2027) (US$ MN)
  • Table 107 RoW Tyrosine Kinase Inhibitors Market By Breast Cancer, Market Forecast (2015-2027) (US$ MN)
  • Table 108 RoW Tyrosine Kinase Inhibitors Market By Other Applications, Market Forecast (2015-2027) (US$ MN)
  • Table 109 RoW Tyrosine Kinase Inhibitors Market By Distribution Channel, Market Forecast (2015-2027) (US$ MN)
  • Table 110 RoW Tyrosine Kinase Inhibitors Market By Independent Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 111 RoW Tyrosine Kinase Inhibitors Market By Online Pharmacies, Market Forecast (2015-2027) (US$ MN)
  • Table 112 RoW Tyrosine Kinase Inhibitors Market By Hospital Pharmacies, Market Forecast (2015-2027) (US$ MN)
目次

The Global Tyrosine Kinase Inhibitors Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising awareness about cancer diagnosis, increasing disease incidences and technological developments among high-quality products.

Based on Product, the market is categorized into Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors, BCR-ABL Tyrosine Kinase Inhibitors and Other Products.

Depending on Application, the market is segregated into Renal Cell Cancer, Lung Cancer, Chronic Myeloid Leukemia (CML), Breast Cancer and Other Applications.

Depending on Distribution Channel , the market is segregated into Independent Pharmacies, Online Pharmacies and Hospital Pharmacies.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • South Africa
  • Others

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Table of Contents

1 Market Outline

  • 1.1 Research Methodology
    • 1.1.1 Research Approach & Sources
  • 1.2 Market Trends
  • 1.3 Regulatory Factors
  • 1.4 Product Analysis
  • 1.5 Application Analysis
  • 1.6 Strategic Benchmarking
  • 1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview

  • 3.1 Current Trends
    • 3.1.1 Rising Awareness about Cancer Diagnosis
    • 3.1.2 Expansion of Research Areas in TKIs
    • 3.1.3 Technological Developments Among High-Quality Products
    • 3.1.4 Growth Opportunities/Investment Opportunities
  • 3.2 Drivers
  • 3.3 Constraints
  • 3.4 Industry Attractiveness
    • 3.4.1 Bargaining power of suppliers
    • 3.4.2 Bargaining power of buyers
    • 3.4.3 Threat of substitutes
    • 3.4.4 Threat of new entrants
    • 3.4.5 Competitive rivalry

4 Tyrosine Kinase Inhibitors Market, By Product

  • 4.1 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
    • DATA TABLE Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Market Forecast to 2027 (US$ MN)
  • 4.2 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
    • DATA TABLE Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Market Forecast to 2027 (US$ MN)
  • 4.3 BCR-ABL Tyrosine Kinase Inhibitors
    • DATA TABLE BCR-ABL Tyrosine Kinase Inhibitors Market Forecast to 2027 (US$ MN)
  • 4.4 Other Products
    • DATA TABLE Other Products Market Forecast to 2027 (US$ MN)

5 Tyrosine Kinase Inhibitors Market, By Application

  • 5.1 Renal Cell Cancer
    • DATA TABLE Renal Cell Cancer Market Forecast to 2027 (US$ MN)
  • 5.2 Lung Cancer
    • DATA TABLE Lung Cancer Market Forecast to 2027 (US$ MN)
  • 5.3 Chronic Myeloid Leukemia (CML)
    • DATA TABLE Chronic Myeloid Leukemia (CML) Market Forecast to 2027 (US$ MN)
  • 5.4 Breast Cancer
    • DATA TABLE Breast Cancer Market Forecast to 2027 (US$ MN)
  • 5.5 Other Applications
    • DATA TABLE Other Applications Market Forecast to 2027 (US$ MN)

6 Tyrosine Kinase Inhibitors Market, By Distribution Channel

  • 6.1 Independent Pharmacies
    • DATA TABLE Independent Pharmacies Market Forecast to 2027 (US$ MN)
  • 6.2 Online Pharmacies
    • DATA TABLE Online Pharmacies Market Forecast to 2027 (US$ MN)
  • 6.3 Hospital Pharmacies
    • DATA TABLE Hospital Pharmacies Market Forecast to 2027 (US$ MN)

7 Tyrosine Kinase Inhibitors Market, By Geography

  • 7.1 North America
    • DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
    • 7.1.1 US
    • 7.1.2 Canada
    • 7.1.3 Mexico
  • 7.2 Europe
    • DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
    • 7.2.1 France
    • 7.2.2 Germany
    • 7.2.3 Italy
    • 7.2.4 Spain
    • 7.2.5 UK
    • 7.2.6 Rest of Europe
  • 7.3 Asia Pacific
    • DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
    • 7.3.1 China
    • 7.3.2 Japan
    • 7.3.3 India
    • 7.3.4 Australia
    • 7.3.5 New Zealand
    • 7.3.6 Rest of Asia Pacific
  • 7.4 Middle East
    • DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
    • 7.4.1 Saudi Arabia
    • 7.4.2 UAE
    • 7.4.3 Rest of Middle East
  • 7.5 Latin America
    • DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Rest of Latin America
  • 7.6 Rest of the World (RoW)
    • DATA TABLE RoW Market Forecast by Countries to 2027 (US$ MN)
    • 7.6.1 South Africa
    • 7.6.2 Others

8 Key Player Activities

  • 8.1 Mergers & Acquisitions
  • 8.2 Partnerships, Joint Venture's, Collaborations and Agreements
  • 8.3 Product Launch & Expansions
  • 8.4 Other Activities

9 Leading Companies

  • 9.1 Tolero Pharmaceutical
  • 9.2 Sanofi
  • 9.3 QIAGEN
  • 9.4 Pfizer
  • 9.5 Onyx pharmaceuticals
  • 9.6 Novartis
  • 9.7 Merck
  • 9.8 Johnson & Johnson
  • 9.9 Incyte Corporation
  • 9.10 GalaxoSmithKline
  • 9.11 Exelixis
  • 9.12 Chugai Pharmaceutical
  • 9.13 Celgene Corporation
  • 9.14 Bristol-Myer Squibb
  • 9.15 Boehringer Ingelheim
  • 9.16 Biogen Idec
  • 9.17 Bayer Healthcare Pharmaceuticals
  • 9.18 AstraZeneca
  • 9.19 Array Pharmaceuticals
  • 9.20 Advenchen Laboratories
Back to Top